Dapagliflozin Evaluation to Improve the LIVEs of Patients With PReserved Ejection Fraction Heart Failure.
- Status
- COMPLETED
- Phase
- PHASE3
Clinical Trials Related to Dapagliflozin
Related studies linked through entity extraction aliases.
Dapagliflozin on Blood Pressure Variability and Ambulatory Arterial Stiffness Index in Hypertension
- Status
- UNKNOWN
- Phase
- PHASE4
Gemigliptin, Dapagliflozin, Empagliflozin DDI Study
- Status
- UNKNOWN
- Phase
- PHASE1
Effect of Dapagliflozin on IAH in T1DM
- Status
- COMPLETED
- Phase
- PHASE2
A Study to Evaluate the Effect of add-on Pioglitazone or Dapagliflozin in Participants With Type 2 Diabetes Mellitus Inadequately Controlled by DPP-4 Inhibitor and Metformin Therapy
- Status
- COMPLETED
- Phase
- PHASE4
A Study for Comparison of Canagliflozin Versus Alternative Antihyperglycemic Treatments on Risk of Heart Failure Hospitalization and Amputation for Participants With Type 2 Diabetes Mellitus and the Subpopulation With Established Cardiovascular Disease
- Status
- COMPLETED
- Phase
- N/A
A Clinical Study to Investigate the Effects of Dapagliflozin on Heart Work, Heart Nutrient Uptake, and Heart Muscle Efficiency in Type 2 Diabetes Patients
- Status
- COMPLETED
- Phase
- PHASE4
Safety, Tolerability, Pharmacokinetics and Pharmacodynamics of DWP16001 After Oral Administration in Healthy Male Volunteers
- Status
- COMPLETED
- Phase
- PHASE1
A Phase IV Study in Drug-Naive Patients With T2DM in China
- Status
- TERMINATED
- Phase
- PHASE4
Effects of 5 Weeks Treatment With Dapagliflozin in Type 2 Diabetes Patients on How the Hormone Insulin Acts on Sugar Uptake in Muscles.
- Status
- COMPLETED
- Phase
- PHASE4
Can Exenatide Prevent Increase in EGP in Response to Dapagliflozin-induced Increase in Glucosuria
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Assess the Effect of Intensive Uric Acid (UA) Lowering Therapy With RDEA3170, Febuxostat, Dapagliflozin on Urinary Excretion of UA
- Status
- COMPLETED
- Phase
- PHASE2
Evaluate the Effects of Dapagliflozin in Patients With Type 2 Diabetes
- Status
- COMPLETED
- Phase
- PHASE4
Cardiovascular Outcomes in Participants With Type 2 Diabetes Mellitus (T2DM)
- Status
- COMPLETED
- Phase
- N/A
Study to Evaluate Safety and Efficacy of Dapagliflozin and Saxagliptin in Patients With Type 2 Diabetes Mellitus (T2DM) Aged 10 to Below 18 Years Old
- Status
- COMPLETED
- Phase
- PHASE3
Effects of DPP4 Inhibitor Versus SGLT2 Inhibitor
- Status
- COMPLETED
- Phase
- PHASE4
The Study Will Evaluate Average 24-hr Sodium Excretion During Dapagliflozin Treatment in Patients With Type 2 Diabetes Mellitus With Preserved or Impaired Renal Function or Non-diabetics With Impaired Renal Function.
- Status
- TERMINATED
- Phase
- PHASE4
Dapagliflozin and Cholesterol Metabolism in Type 2 Diabetes (DM2)
- Status
- COMPLETED
- Phase
- PHASE4
A Study to Evaluate the Effect of Dapagliflozin on Renal Outcomes and Cardiovascular Mortality in Patients With Chronic Kidney Disease
- Status
- COMPLETED
- Phase
- PHASE3
Study to Evaluate the Effect of Dapagliflozin on the Incidence of Worsening Heart Failure or Cardiovascular Death in Patients With Chronic Heart Failure
- Status
- COMPLETED
- Phase
- PHASE3